Selective inhibition of the inducible nitric oxide synthase by aminoguanidine
Thomas P. Misko(Monsanto (United States)), Mark G. Currie(Flinders University), William M. Moore(Monsanto (United States)), Michael L. McDaniel(Washington University in St. Louis), John A. Corbett(Medical College of Wisconsin), Ronald G. Tilton(Washington University in St. Louis), Thomas P. Kasten(Monsanto (United States)), G. Allen Nickols(Monsanto (United States)), Joseph R. Williamson(University College London)
Cited by 727
Related Papers
Molecular Docking and High-Throughput Screening for Novel Inhibitors of Protein Tyrosine Phosphatase-1B
|Journal of Medicinal Chemistry|2002|467
Potentiation of osteoclast bone-resorption activity by inhibition of nitric oxide synthase.
|Proceedings of the National Academy of Sciences|1994|243
Analysis of the phosphofructokinase subunits and isoenzymes in human tissues
|Biochemical Journal|1988|157
cAMP Dose-dependently Prevents Palmitate-induced Apoptosis by Both Protein Kinase A- and cAMP-Guanine Nucleotide Exchange Factor-dependent Pathways in β-Cells
|Journal of Biological Chemistry|2004|119
Kinetic Characterization of Human Glutamine-fructose-6-phosphate Amidotransferase I
|Journal of Biological Chemistry|2002|105